Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Addition to Fluticasone for Seasonal Allergic Rhinitis
NCT01103934Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Jun 2010
- Primary completion
- Jul 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Fluticasone + Vitamin D3 with Fluticasone + Placebo (2 arms). Primary endpoint: Total Nasal Symptom Score at 2 weeks. Started Jun 2010; status: completed.
02
Drugs
vitamin d
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01103934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01103934.